Outsourcing formulation development & manufacturing: Connecting your project to the right service provider
The CDMO market is projected to grow from $273 billion in 2026 to nearly $581 billion by 2034, driven by complex formulations and highly potent APIs that demand specialized partners. Samsung Biologics' Derrick Katayama highlights surging demand for high-concentration biologics enabling subcutaneous delivery, as the company's S-HiCon™ platform helps clients overcome solubility and stability challenges at concentrations exceeding 100 mg/mL.
Read the full report to explore how 30+ CDMOs are solving real-world formulation and manufacturing challenges.
The CDMO market is projected to grow from $273 billion in 2026 to nearly $581 billion by 2034, driven by complex formulations and highly potent APIs that demand specialized partners. Samsung Biologics' Derrick Katayama highlights surging demand for high-concentration biologics enabling subcutaneous delivery, as the company's S-HiCon™ platform helps clients overcome solubility and stability challenges at concentrations exceeding 100 mg/mL.
Read the full report to explore how 30+ CDMOs are solving real-world formulation and manufacturing challenges.
Share article
Related Content